HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emiliano Santarnecchi Selected Research

Emiliano Santarnecchi Research Topics

Disease

5Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2017
3Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2019 - 03/2012
2Dementia (Dementias)
01/2022 - 01/2020
2Cognitive Dysfunction
05/2021 - 01/2020
2Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2021 - 05/2016
2Mental Disorders (Mental Disorder)
03/2020 - 05/2016
1Neuroinflammatory Diseases
01/2022
1Disease Progression
01/2022
1Seizures (Absence Seizure)
01/2021
1Pruritus (Itching)
03/2020
1Parkinson Disease (Parkinson's Disease)
01/2020
1Autism Spectrum Disorder
01/2020
1Neurodevelopmental Disorders
01/2019
1Wounds and Injuries (Trauma)
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018
1Stroke (Strokes)
09/2017
1Brain Injuries (Brain Injury)
09/2017
1Delirium
06/2017
1Hypoxia (Hypoxemia)
01/2017
1Persistent Vegetative State (Vegetative State)
01/2017
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2017
1Consciousness Disorders
01/2017
1Migraine Disorders (Migraine)
05/2016
1Tremor (Tremors)
05/2016
1Chronic Pain
05/2016
1Epilepsy (Aura)
05/2016
1Dystonia (Limb Dystonia)
05/2016
1Multiple Sclerosis
01/2015
1Fatigue
01/2015
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2013
1Panic Disorder (Panic Attack)
01/2013
1Anxiety Disorders (Anxiety Disorder)
01/2013

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2017
3salicylhydroxamic acid (SHAM)IBA
05/2021 - 01/2017
3Pharmaceutical PreparationsIBA
01/2017 - 03/2012
2Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2020
1Cholinergic Agents (Cholinergics)IBA
05/2021
1Peptides (Polypeptides)IBA
01/2020
1tau Proteins (tau Protein)IBA
01/2020
1Biological ProductsIBA
01/2018
1Levetiracetam (Keppra)FDA LinkGeneric
01/2017
1Amantadine (Aman)FDA LinkGeneric
01/2015
1N 30IBA
01/2013
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2013

Therapy/Procedure

8Transcranial Direct Current Stimulation
01/2022 - 05/2016
4Therapeutics
01/2022 - 01/2013
3Transcranial Magnetic Stimulation
01/2021 - 05/2016
2Aftercare (After-Treatment)
01/2019 - 01/2015
1Cognitive Training
01/2019
1Vagus Nerve Stimulation
05/2016
1Deep Brain Stimulation
05/2016